Physician profile
Nathan Singh
NPI 1730523499
$1,207.51
in general payments reported to CMS, 2019-2025
20 companies · $234 in 2025
The $234 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $19.20 · 2022: $237 · 2023: $43.01 · 2024: $285 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $561.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $328.21 | 2024-2025 | |
| Gilead Sciences, INC. | $175.97 | 2022 | |
| Amgen INC. | $153.48 | 2019 | |
| Glaxosmithkline, LLC. | $68.82 | 2022-2024 | Bexsero |
| Takeda Pharmaceuticals U.S.A., INC. | $56.70 | 2019 | |
| Merck Sharp & Dohme LLC | $48.77 | 2019 | |
| Pfizer INC. | $45.70 | 2022-2024 | |
| Dynavax Technologies Corporation | $43.43 | 2024 | Heplisav-B |
| Fidia Pharma USA INC. | $38.38 | 2019-2020 | |
| Novo Nordisk INC | $30.34 | 2024 | |
| Therapeuticsmd, INC. | $29.49 | 2019 | |
| Bavarian Nordic A/S | $27.92 | 2024 | Vaxchora |
| Medtronic Vascular, INC. | $26.48 | 2019 | |
| Averitas Pharma INC. | $25.37 | 2023 | Qutenza |
| Coopersurgical, INC. | $24.16 | 2024 | Paragard T 380a |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $21.96 | 2019 | |
| Depuy Synthes Sales INC. | $18.83 | 2019 | |
| Organon LLC | $17.64 | 2023 | |
| Amag Pharmaceuticals, INC. | $14.78 | 2019 | |
| Grt US Holding, INC. | $11.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.